Bharat Biotech Seeks DCGI’s Nod To Extend Shelf Life Of Covaxin
Bharat Biotech has written to the India’s drug regulator seeking an extension of the shelf-life of its indigenously developed COVID-19 vaccine Covaxin from six to 24 months, sources said on…
Share